Non-Viral Vectors for Delivery of Nucleic Acid Therapies for Cancer
The research and development of non-viral gene therapy has been extensive over the past decade and has received a big push thanks to the recent successful approval of non-viral nucleic acid therapy products. Despite these developments, nucleic acid therapy applications in cancer have been limited. O...
Saved in:
Published in | Biotech (Basel) Vol. 11; no. 1; p. 6 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Basel
MDPI AG
07.03.2022
MDPI |
Subjects | |
Online Access | Get full text |
ISSN | 2673-6284 2673-6284 |
DOI | 10.3390/biotech11010006 |
Cover
Abstract | The research and development of non-viral gene therapy has been extensive over the past decade and has received a big push thanks to the recent successful approval of non-viral nucleic acid therapy products. Despite these developments, nucleic acid therapy applications in cancer have been limited. One of the main causes of this has been the imbalance in development of delivery vectors as compared with sophisticated nucleic acid payloads, such as siRNA, mRNA, etc. This paper reviews non-viral vectors that can be used to deliver nucleic acids for cancer treatment. It discusses various types of vectors and highlights their current applications. Additionally, it discusses a perspective on the current regulatory landscape to facilitate the commercial translation of gene therapy. |
---|---|
AbstractList | The research and development of non-viral gene therapy has been extensive over the past decade and has received a big push thanks to the recent successful approval of non-viral nucleic acid therapy products. Despite these developments, nucleic acid therapy applications in cancer have been limited. One of the main causes of this has been the imbalance in development of delivery vectors as compared with sophisticated nucleic acid payloads, such as siRNA, mRNA, etc. This paper reviews non-viral vectors that can be used to deliver nucleic acids for cancer treatment. It discusses various types of vectors and highlights their current applications. Additionally, it discusses a perspective on the current regulatory landscape to facilitate the commercial translation of gene therapy. The research and development of non-viral gene therapy has been extensive over the past decade and has received a big push thanks to the recent successful approval of non-viral nucleic acid therapy products. Despite these developments, nucleic acid therapy applications in cancer have been limited. One of the main causes of this has been the imbalance in development of delivery vectors as compared with sophisticated nucleic acid payloads, such as siRNA, mRNA, etc. This paper reviews non-viral vectors that can be used to deliver nucleic acids for cancer treatment. It discusses various types of vectors and highlights their current applications. Additionally, it discusses a perspective on the current regulatory landscape to facilitate the commercial translation of gene therapy.The research and development of non-viral gene therapy has been extensive over the past decade and has received a big push thanks to the recent successful approval of non-viral nucleic acid therapy products. Despite these developments, nucleic acid therapy applications in cancer have been limited. One of the main causes of this has been the imbalance in development of delivery vectors as compared with sophisticated nucleic acid payloads, such as siRNA, mRNA, etc. This paper reviews non-viral vectors that can be used to deliver nucleic acids for cancer treatment. It discusses various types of vectors and highlights their current applications. Additionally, it discusses a perspective on the current regulatory landscape to facilitate the commercial translation of gene therapy. |
Author | Kulkarni, Tanmay Dasgupta, Aneesha Bhattacharya, Deep Kanvinde, Shrey Deodhar, Suyash |
AuthorAffiliation | 1 Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA; tkulkarni68@gmail.com (T.K.); deep.bhattacharya1991@gmail.com (D.B.) 3 Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA; dasgupta.aneesha@mayo.edu 2 Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA; suyashsanjay.deodhar@unmc.edu |
AuthorAffiliation_xml | – name: 3 Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA; dasgupta.aneesha@mayo.edu – name: 2 Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA; suyashsanjay.deodhar@unmc.edu – name: 1 Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA; tkulkarni68@gmail.com (T.K.); deep.bhattacharya1991@gmail.com (D.B.) |
Author_xml | – sequence: 1 givenname: Shrey surname: Kanvinde fullname: Kanvinde, Shrey – sequence: 2 givenname: Tanmay surname: Kulkarni fullname: Kulkarni, Tanmay – sequence: 3 givenname: Suyash orcidid: 0000-0003-1536-6761 surname: Deodhar fullname: Deodhar, Suyash – sequence: 4 givenname: Deep surname: Bhattacharya fullname: Bhattacharya, Deep – sequence: 5 givenname: Aneesha surname: Dasgupta fullname: Dasgupta, Aneesha |
BookMark | eNp1kU1v3CAQhlGVqknTnHu11EsvboYPG7hUijb9iBSllzRXhGHIsvKaLdiR8u9LuqnUrNQTCJ73YZh5S46mNCEh7yl84lzD-RDTjG5NKVAA6F-RE9ZL3vZMiaN_9sfkrJRNJZjUXEj9hhzzTjGmqDghq5s0tXcx27G5QzenXJqQcnOJY3zA_Nik0NwsbsTomgsXfXO7xmx3EffYyk4O8zvyOtix4Nnzekp-fv1yu_reXv_4drW6uG6d6MXcBlkLwE5LzigyqWTQXoGyNkjPPe-HgBqkggCAWuvB-l5Qyi2T0IVBAD8lV3uvT3ZjdjlubX40yUbz5yDle2PzHGu1hqIDBc4L4UGwXgwDcMsZduh7GCStrs97124ZtugdTnPtwQvpy5sprs19ejCaiU6DqIKPz4Kcfi1YZrONxeE42gnTUgzrlYaOKc0q-uEA3aQlT7VVlRKMC0E1r1S3p1xOpWQMxsXZzjE9vR9HQ8E8Td0cTL3mzg9yfz_xv8RvekivNw |
CitedBy_id | crossref_primary_10_1016_j_eurpolymj_2024_113624 crossref_primary_10_3389_fphar_2022_984981 crossref_primary_10_3390_pharmaceutics16040494 crossref_primary_10_3390_pharmaceutics15051406 crossref_primary_10_3390_ijms24043375 crossref_primary_10_3390_jpm12101736 crossref_primary_10_3390_pharmaceutics16111376 crossref_primary_10_1002_slct_202402903 crossref_primary_10_1002_adtp_202400126 crossref_primary_10_1016_j_carpta_2023_100404 crossref_primary_10_1016_j_colsurfa_2024_135575 crossref_primary_10_3390_app142310892 crossref_primary_10_1021_acs_molpharmaceut_3c00907 crossref_primary_10_1016_j_jddst_2022_104113 crossref_primary_10_1186_s12951_025_03172_w crossref_primary_10_20517_jtgg_2023_50 crossref_primary_10_3389_fnagi_2024_1347987 crossref_primary_10_1186_s12967_022_03747_3 crossref_primary_10_3390_polym15061400 crossref_primary_10_1016_j_jconrel_2023_01_084 crossref_primary_10_3390_biotech12020034 |
Cites_doi | 10.1038/sj.gt.3300471 10.1080/15583724.2011.566404 10.1039/b900666b 10.1208/s12249-014-0142-7 10.1016/0005-2736(77)90099-2 10.1038/nature04688 10.1146/annurev-med-041217-010829 10.3390/biom9080330 10.1103/PhysRevE.81.051909 10.1080/02652040802390156 10.1073/pnas.192581499 10.1021/acsami.7b09624 10.3390/ijms19010195 10.1016/j.biomaterials.2015.11.032 10.3390/vaccines9040359 10.3390/pharmaceutics12020093 10.1021/acsomega.8b02757 10.1080/1061186X.2018.1519029 10.20944/preprints201803.0005.v1 10.1016/j.jconrel.2016.12.017 10.1038/bjp.2008.349 10.2147/IJN.S33666 10.3390/molecules23040938 10.1016/j.apmt.2018.05.002 10.1021/bp00004a009 10.3390/cells9010137 10.1021/mp500469n 10.1016/j.addr.2020.06.014 10.1002/jgm.187 10.1002/jgm.173 10.1002/wnan.1598 10.1016/j.bbamem.2014.08.022 10.1021/ma035629b 10.20944/preprints202201.0372.v1 10.1038/s41541-021-00292-w 10.3390/molecules23112849 10.1016/j.jconrel.2015.09.043 10.3390/metabo11020106 10.1039/D0RA02574G 10.1039/C5SM01403D 10.1016/j.addr.2012.09.037 10.1016/j.tibtech.2013.09.007 10.4155/tde.13.80 10.1038/sj.gt.3300454 10.1016/B978-0-12-800148-6.00002-X 10.1155/2013/972913 10.1016/j.cell.2009.02.024 10.1093/jnci/djm279 10.1016/j.actbio.2009.04.021 10.1126/science.aav5697 10.1016/j.jconrel.2003.08.017 10.3390/molecules25173982 10.1016/j.biomaterials.2014.04.095 10.1021/acsnano.1c04996 10.1021/bc0001084 10.1016/j.jconrel.2019.09.018 10.1089/hum.2017.209 10.3390/md17060381 10.1021/mp300188f 10.1016/j.nano.2016.06.014 10.3389/fphar.2018.00971 10.1016/j.susc.2004.03.049 10.2147/IJN.S42440 10.1016/j.jconrel.2005.01.008 10.1038/s41598-020-78123-6 10.1016/j.ymthe.2017.01.024 10.1016/j.ijpharm.2019.04.078 10.1038/s43018-021-00313-6 10.1016/j.jconrel.2012.06.036 10.1021/acs.jpcb.6b10775 10.3390/pharmaceutics12020102 10.1111/1750-3841.14950 10.1021/mp300449t 10.1093/femsre/fuab035 10.1016/j.jconrel.2012.07.006 10.1016/j.progpolymsci.2013.07.005 10.1016/j.ijpharm.2008.08.003 10.1038/s41598-019-52142-4 10.1016/j.biomaterials.2013.09.061 10.1158/1078-0432.CCR-06-0021 10.1200/JCO.2019.37.15_suppl.2523 10.1016/j.ijpharm.2020.119269 10.1016/j.biomaterials.2013.11.026 10.3390/pharmaceutics4010130 10.2217/nnm-2018-0510 10.3390/molecules24142570 10.1016/j.addr.2015.01.007 10.1039/C7TB01895A 10.1016/j.addr.2005.09.017 10.1016/j.ijpharm.2018.05.045 10.1073/pnas.0607057103 10.3389/fonc.2019.00297 10.1016/j.xphs.2021.09.011 10.1021/bc1000609 10.1038/s41467-021-23668-x 10.1186/s12951-021-00777-9 10.1016/j.biomaterials.2012.12.006 10.1038/s41598-017-02531-4 10.4155/tde-2018-0035 10.1021/acs.molpharmaceut.6b00646 10.4155/tde-2018-0020 10.1517/17425247.2011.610790 10.1038/sj.gt.3302050 10.1021/acs.chemrev.5b00346 10.1038/nature23003 10.1159/000495956 10.1021/acsomega.1c01343 10.1039/C6NR04489A 10.3109/1061186X.2014.950663 10.1208/s12249-020-01745-6 10.1071/CH07052 10.1080/09205063.2012.690282 10.1586/erm.09.15 10.1021/mp8000233 10.3390/molecules24010004 10.1016/j.ijpharm.2006.02.026 10.1038/s41565-019-0591-y 10.1182/blood-2013-01-306647 10.1021/cr970027+ 10.1016/j.bbagen.2011.10.013 10.1021/ma1012495 10.1016/0005-2736(90)90440-Y 10.1038/s41598-018-25930-7 10.1016/j.nbt.2018.09.005 10.1016/j.addr.2017.07.021 10.1358/dof.2009.34.9.1413267 10.1016/j.ijpharm.2017.06.026 10.1021/mp4001662 10.1016/j.addr.2013.09.004 10.1021/bm401204n 10.1021/acsnano.8b07858 10.1038/s41578-021-00358-0 10.1016/0014-5793(90)81016-H 10.1021/acsbiomaterials.1c00110 10.1016/j.biomaterials.2014.01.040 10.1016/S0169-409X(00)00123-X 10.1016/j.actbio.2018.10.027 10.1021/acs.macromol.7b01470 10.1016/j.bbamem.2004.04.003 10.1021/acsbiomaterials.0c00115 10.5772/54781 10.1016/j.jconrel.2011.10.013 10.1016/j.addr.2004.01.009 10.1016/j.mattod.2015.06.003 10.1021/acs.molpharmaceut.5b00894 10.1016/j.xphs.2021.03.024 10.1038/mtna.2013.45 10.1038/mtna.2012.28 10.1097/00001813-200403000-00009 10.5772/54862 10.1038/s41563-020-0674-z 10.3390/ma2020307 |
ContentType | Journal Article |
Copyright | 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 by the authors. 2022 |
Copyright_xml | – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 by the authors. 2022 |
DBID | AAYXX CITATION 8FE 8FH ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU COVID DWQXO GNUQQ HCIFZ LK8 M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.3390/biotech11010006 |
DatabaseName | CrossRef ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Coronavirus Research Database ProQuest Central ProQuest Central Student SciTech Premium Collection (via ProQuest) ProQuest Biological Science Collection Biological Science Database (Proquest) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Biological Science Collection ProQuest Central Essentials ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection Biological Science Database ProQuest SciTech Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Academic UKI Edition Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic |
DatabaseTitleList | CrossRef Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 2673-6284 |
ExternalDocumentID | oai_doaj_org_article_1ec080cd44d04264bb03a32e5ed60b71 PMC9245904 10_3390_biotech11010006 |
GroupedDBID | AADQD AAFWJ AAYXX ABDBF ACUHS AFKRA AFPKN AFZYC ALMA_UNASSIGNED_HOLDINGS BBNVY BENPR BHPHI CCPQU CITATION GROUPED_DOAJ HCIFZ M7P MODMG M~E PGMZT PHGZM PHGZT PIMPY RPM 8FE 8FH ABUWG AZQEC COVID DWQXO GNUQQ LK8 PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c464t-f7279e597321e2787f9d808aaf7d3d36bfe90780f00e999bad64113a2705fb403 |
IEDL.DBID | BENPR |
ISSN | 2673-6284 |
IngestDate | Wed Aug 27 01:30:28 EDT 2025 Thu Aug 21 18:02:43 EDT 2025 Fri Sep 05 14:42:31 EDT 2025 Fri Jul 25 12:08:18 EDT 2025 Thu Apr 24 23:04:47 EDT 2025 Tue Jul 01 03:02:12 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c464t-f7279e597321e2787f9d808aaf7d3d36bfe90780f00e999bad64113a2705fb403 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0003-1536-6761 |
OpenAccessLink | https://www.proquest.com/docview/2642344193?pq-origsite=%requestingapplication%&accountid=15518 |
PMID | 35822814 |
PQID | 2642344193 |
PQPubID | 2032360 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_1ec080cd44d04264bb03a32e5ed60b71 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9245904 proquest_miscellaneous_2689052892 proquest_journals_2642344193 crossref_citationtrail_10_3390_biotech11010006 crossref_primary_10_3390_biotech11010006 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-03-07 |
PublicationDateYYYYMMDD | 2022-03-07 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-07 day: 07 |
PublicationDecade | 2020 |
PublicationPlace | Basel |
PublicationPlace_xml | – name: Basel |
PublicationTitle | Biotech (Basel) |
PublicationYear | 2022 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Moitra (ref_141) 2021; 7 Baker (ref_91) 1997; 4 Zhu (ref_110) 2015; 12 Solano (ref_19) 2020; 10 Traverso (ref_44) 2013; 2013 Hwang (ref_18) 2001; 12 Abdelhady (ref_80) 2004; 558 ref_11 Ramamoorth (ref_15) 2015; 9 Conry (ref_145) 1995; 55 Figueroa (ref_85) 2014; 35 ref_96 Akinc (ref_118) 2019; 14 ref_17 Wiedenmann (ref_155) 2019; 84 Abdelwahab (ref_35) 2014; 22 Risnayanti (ref_101) 2018; 8 Buck (ref_114) 2019; 13 Zaromytidou (ref_1) 2021; 2 Belliveau (ref_121) 2012; 1 ref_125 Liu (ref_62) 2016; 8 Kulkarni (ref_116) 2020; 19 Chanock (ref_4) 2018; 362 Luo (ref_9) 2009; 136 Bouard (ref_12) 2009; 157 Tekedereli (ref_153) 2013; 2 Wenz (ref_45) 2006; 106 Gallarate (ref_154) 2009; 26 Hu (ref_52) 2006; 315 Huang (ref_64) 2014; Volume 88 Thomas (ref_68) 2002; 99 Bhattacharya (ref_115) 2009; 31 Leng (ref_26) 2009; 34 Kim (ref_159) 2008; 5 Kulkarni (ref_46) 2013; 10 Chaturvedi (ref_34) 2011; 8 Zhao (ref_113) 2014; 88 Evans (ref_42) 2016; 12 Pei (ref_142) 2004; 15 Bagheri (ref_137) 2019; 315 Kanamala (ref_138) 2019; 14 Zhou (ref_8) 2017; 115 Kim (ref_59) 2003; 93 ref_72 Wang (ref_132) 2021; 19 Lutz (ref_31) 2007; 60 Noble (ref_131) 2014; 32 Kyriakidis (ref_6) 2021; 6 Bono (ref_73) 2019; 4 ref_77 ref_76 Wang (ref_99) 2009; 9 Gkouvatsos (ref_25) 2012; 1820 ref_74 Ciani (ref_150) 2004; 1664 Hou (ref_124) 2021; 6 ref_156 Tenchov (ref_122) 2021; 15 Lai (ref_24) 2014; 35 Zhang (ref_140) 2019; 566 Kiaie (ref_148) 2020; 581 Su (ref_102) 2012; 7 Franco (ref_136) 2013; 4 ref_82 Liu (ref_84) 2017; 530 Cordes (ref_90) 1990; 6 Bhattacharya (ref_29) 2020; 6 Goswami (ref_14) 2019; 9 Li (ref_38) 2013; 8 Evans (ref_33) 2017; 14 Bhattacharya (ref_28) 2021; 6 Wang (ref_127) 2005; 104 Kauffman (ref_65) 2020; 156 Lee (ref_61) 2012; 162 Arima (ref_22) 2012; 9 Yu (ref_55) 2014; 35 Burris (ref_147) 2019; 37 Janes (ref_51) 2001; 47 Kang (ref_79) 2012; 164 Allen (ref_123) 2013; 65 Bingham (ref_126) 2010; 81 ref_50 Tariq (ref_86) 2020; 10 Weyhers (ref_157) 2006; 61 Blume (ref_134) 1990; 1029 Klibanov (ref_135) 1990; 268 ref_57 Santos (ref_53) 2015; 11 Lu (ref_36) 2004; 56 Wani (ref_87) 2017; 7 Wiseman (ref_92) 2003; 10 Durymanov (ref_10) 2018; 9 Layek (ref_54) 2013; 14 Liu (ref_162) 2021; 111 Bielas (ref_3) 2006; 103 Bhattacharya (ref_27) 2017; 5 Kesharwani (ref_75) 2015; 18 Lim (ref_89) 2017; 9 Gray (ref_152) 2008; 100 ref_161 Grimaldi (ref_95) 2019; 49 Ebtekara (ref_100) 2019; 18 Rybczynska (ref_32) 2015; 1848 Dehghan (ref_71) 2018; 12 Sahin (ref_146) 2017; 547 Wightman (ref_93) 2001; 3 Ozcan (ref_149) 2015; 87 Peetla (ref_120) 2013; 65 Kesharwani (ref_20) 2014; 39 Maiti (ref_70) 2004; 37 Hall (ref_67) 2017; 25 Halder (ref_151) 2006; 12 Ziebarth (ref_97) 2017; 121 Mingozzi (ref_16) 2013; 122 Roggers (ref_88) 2014; 15 Mirahadi (ref_160) 2018; 9 Dehn (ref_30) 2011; 51 Arima (ref_37) 2012; 4 Liu (ref_128) 2021; 12 Liu (ref_23) 2014; 35 Kamaly (ref_98) 2016; 116 Benhabbour (ref_130) 2012; 158 Badwaik (ref_47) 2016; 84 Chang (ref_60) 2010; 21 Israelachvili (ref_119) 1977; 470 Salameh (ref_63) 2020; 12 Khan (ref_103) 2019; 9 Lin (ref_43) 2013; 10 Freeman (ref_69) 2013; 24 ref_39 Tamura (ref_48) 2013; 34 Li (ref_40) 2019; 27 Gautam (ref_117) 2021; 12 Zimmermann (ref_158) 2006; 441 Wang (ref_2) 2018; 51 Bennett (ref_144) 2019; 70 Patel (ref_163) 2021; 45 Kanvinde (ref_107) 2018; 82 ref_106 Li (ref_83) 2018; 546 ref_108 He (ref_139) 2018; 29 An (ref_81) 2017; 50 Li (ref_105) 2015; 219 Vasumathi (ref_78) 2010; 43 Vroman (ref_104) 2009; 2 ref_109 Tang (ref_66) 1997; 4 Deodhar (ref_129) 2018; 9 Li (ref_143) 2021; 32 Xie (ref_111) 2017; 246 Srivastava (ref_13) 2021; 110 ref_41 Moreira (ref_58) 2009; 5 Uchegbu (ref_21) 2005; 57 Xie (ref_112) 2016; 13 Deodhar (ref_133) 2020; 21 ref_49 Kichler (ref_94) 2001; 3 ref_5 Opanasopit (ref_56) 2008; 364 ref_7 |
References_xml | – volume: 4 start-page: 773 year: 1997 ident: ref_91 article-title: Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery publication-title: Gene Ther. doi: 10.1038/sj.gt.3300471 – volume: 51 start-page: 214 year: 2011 ident: ref_30 article-title: Synthetic Strategies for the Design of Peptide/Polymer Conjugates publication-title: Polym. Rev. doi: 10.1080/15583724.2011.566404 – volume: 31 start-page: 4632 year: 2009 ident: ref_115 article-title: Advances in gene delivery through molecular design of cationic lipids publication-title: Chem. Commun. doi: 10.1039/b900666b – volume: 15 start-page: 1163 year: 2014 ident: ref_88 article-title: The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal publication-title: AAPS PharmSciTech doi: 10.1208/s12249-014-0142-7 – volume: 470 start-page: 185 year: 1977 ident: ref_119 article-title: Theory of self-assembly of lipid bilayers and vesicles publication-title: Biochim. Biophys. Acta-Biomembr. doi: 10.1016/0005-2736(77)90099-2 – volume: 441 start-page: 111 year: 2006 ident: ref_158 article-title: RNAi-mediated gene silencing in non-human primates publication-title: Nature doi: 10.1038/nature04688 – volume: 70 start-page: 307 year: 2019 ident: ref_144 article-title: Therapeutic Antisense Oligonucleotides Are Coming of Age publication-title: Annu. Rev. Med. doi: 10.1146/annurev-med-041217-010829 – volume: Volume 88 start-page: 231 year: 2014 ident: ref_64 article-title: Chapter Eight-Polymers for Nucleic Acid Transfer—An Overview publication-title: Nonviral Vectors for Gene Therapy – ident: ref_77 doi: 10.3390/biom9080330 – volume: 81 start-page: 51909 year: 2010 ident: ref_126 article-title: Undulation instability in a bilayer lipid membrane due to electric field interaction with lipid dipoles publication-title: Phys. Rev. E doi: 10.1103/PhysRevE.81.051909 – volume: 26 start-page: 394 year: 2009 ident: ref_154 article-title: Preparation of solid lipid nanoparticles from W/O/W emulsions: Preliminary studies on insulin encapsulation publication-title: J. Microencapsul. doi: 10.1080/02652040802390156 – volume: 99 start-page: 14640 year: 2002 ident: ref_68 article-title: Enhancing polyethylenimine’s delivery of plasmid DNA into mammalian cells publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.192581499 – volume: 9 start-page: 31543 year: 2017 ident: ref_89 article-title: Polyamidoamine-Decorated Nanodiamonds as a Hybrid Gene Delivery Vector and siRNA Structural Characterization at the Charged Interfaces publication-title: ACS Appl. Mater. Interfaces doi: 10.1021/acsami.7b09624 – ident: ref_125 doi: 10.3390/ijms19010195 – volume: 84 start-page: 86 year: 2016 ident: ref_47 article-title: Structure-property relationship for in vitro siRNA delivery performance of cationic 2-hydroxypropyl-β-cyclodextrin: PEG-PPG-PEG polyrotaxane vectors publication-title: Biomaterials doi: 10.1016/j.biomaterials.2015.11.032 – volume: 9 start-page: GE1 year: 2015 ident: ref_15 article-title: Non viral vectors in gene therapy- an overview publication-title: J. Clin. Diagn. Res. – ident: ref_161 doi: 10.3390/vaccines9040359 – ident: ref_39 doi: 10.3390/pharmaceutics12020093 – volume: 4 start-page: 6796 year: 2019 ident: ref_73 article-title: Role of Generation on Successful DNA Delivery of PAMAM–(Guanidino)Neomycin Conjugates publication-title: ACS Omega doi: 10.1021/acsomega.8b02757 – volume: 27 start-page: 423 year: 2019 ident: ref_40 article-title: Stimuli-responsive nanoscale drug delivery systems for cancer therapy publication-title: J. Drug Target. doi: 10.1080/1061186X.2018.1519029 – ident: ref_57 doi: 10.20944/preprints201803.0005.v1 – volume: 61 start-page: 539 year: 2006 ident: ref_157 article-title: Solid lipid nanoparticles (SLN)-Effects of lipid composition on in vitro degradation and in vivo toxicity publication-title: Pharmazie – volume: 246 start-page: 110 year: 2017 ident: ref_111 article-title: Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy publication-title: J. Control. Release doi: 10.1016/j.jconrel.2016.12.017 – volume: 157 start-page: 153 year: 2009 ident: ref_12 article-title: Viral vectors: From virology to transgene expression publication-title: Br. J. Pharmacol. doi: 10.1038/bjp.2008.349 – volume: 7 start-page: 4269 year: 2012 ident: ref_102 article-title: PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S33666 – ident: ref_76 doi: 10.3390/molecules23040938 – volume: 32 start-page: 1382 year: 2021 ident: ref_143 article-title: Preclinical Safety Evaluation of a Recombinant Plasmid Vector Encoding Mature Human Neutrophil Peptide-1 by Repeated Local Administrations in Nonhuman Primates publication-title: Hum. Gene Ther. – volume: 12 start-page: 177 year: 2018 ident: ref_71 article-title: PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy publication-title: Appl. Mater. Today doi: 10.1016/j.apmt.2018.05.002 – volume: 6 start-page: 283 year: 1990 ident: ref_90 article-title: Precipitation of Nucleic Acids with Poly (ethyleneimine) publication-title: Biotechnol. Prog. doi: 10.1021/bp00004a009 – ident: ref_5 doi: 10.3390/cells9010137 – volume: 12 start-page: 332 year: 2015 ident: ref_110 article-title: Self-immolative polycations as gene delivery vectors and prodrugs targeting polyamine metabolism in cancer publication-title: Mol. Pharm. doi: 10.1021/mp500469n – volume: 156 start-page: 119 year: 2020 ident: ref_65 article-title: Polymeric vehicles for nucleic acid delivery publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2020.06.014 – volume: 3 start-page: 362 year: 2001 ident: ref_93 article-title: Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo publication-title: J. Gene Med. doi: 10.1002/jgm.187 – volume: 3 start-page: 135 year: 2001 ident: ref_94 article-title: Polyethylenimine-mediated gene delivery: A mechanistic study publication-title: J. Gene Med. doi: 10.1002/jgm.173 – volume: 12 start-page: e1598 year: 2020 ident: ref_63 article-title: Polymer-mediated gene therapy: Recent advances and merging of delivery techniques publication-title: Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. doi: 10.1002/wnan.1598 – volume: 1848 start-page: 2703 year: 2015 ident: ref_32 article-title: Potential applications for sigma receptor ligands in cancer diagnosis and therapy publication-title: Biochim. Biophys. Acta-Biomembr. doi: 10.1016/j.bbamem.2014.08.022 – volume: 37 start-page: 6236 year: 2004 ident: ref_70 article-title: Structure of PAMAM Dendrimers: Generations 1 through 11 publication-title: Macromolecules doi: 10.1021/ma035629b – ident: ref_96 doi: 10.20944/preprints202201.0372.v1 – volume: 6 start-page: 28 year: 2021 ident: ref_6 article-title: SARS-CoV-2 vaccines strategies: A comprehensive review of phase 3 candidates publication-title: NPJ Vaccines doi: 10.1038/s41541-021-00292-w – ident: ref_72 doi: 10.3390/molecules23112849 – volume: 219 start-page: 369 year: 2015 ident: ref_105 article-title: Polymeric drugs: Advances in the development of pharmacologically active polymers publication-title: J. Control. Release doi: 10.1016/j.jconrel.2015.09.043 – ident: ref_108 doi: 10.3390/metabo11020106 – volume: 10 start-page: 25557 year: 2020 ident: ref_19 article-title: Efficient modification of PAMAM G1 dendrimer surface with β-cyclodextrin units by CuAAC: Impact on the water solubility and cytotoxicity publication-title: RSC Adv. doi: 10.1039/D0RA02574G – volume: 11 start-page: 8113 year: 2015 ident: ref_53 article-title: Functionalized chitosan derivatives as nonviral vectors: Physicochemical properties of acylated N,N,N-trimethyl chitosan/oligonucleotide nanopolyplexes publication-title: Soft Matter doi: 10.1039/C5SM01403D – volume: 65 start-page: 36 year: 2013 ident: ref_123 article-title: Liposomal drug delivery systems: From concept to clinical applications publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2012.09.037 – volume: 32 start-page: 32 year: 2014 ident: ref_131 article-title: Ligand-targeted liposome design: Challenges and fundamental considerations publication-title: Trends Biotechnol. doi: 10.1016/j.tibtech.2013.09.007 – volume: 4 start-page: 1099 year: 2013 ident: ref_136 article-title: pH-sensitive liposomes for drug delivery in cancer treatment publication-title: Ther. Deliv. doi: 10.4155/tde.13.80 – volume: 4 start-page: 823 year: 1997 ident: ref_66 article-title: The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes publication-title: Gene Ther. doi: 10.1038/sj.gt.3300454 – volume: 88 start-page: 13 year: 2014 ident: ref_113 article-title: Lipid nanoparticles for gene delivery publication-title: Adv. Genet. doi: 10.1016/B978-0-12-800148-6.00002-X – volume: 2013 start-page: 972913 year: 2013 ident: ref_44 article-title: Role of glutathione in cancer progression and chemoresistance publication-title: Oxid. Med. Cell. Longev. doi: 10.1155/2013/972913 – volume: 136 start-page: 823 year: 2009 ident: ref_9 article-title: Principles of cancer therapy: Oncogene and non-oncogene addiction publication-title: Cell doi: 10.1016/j.cell.2009.02.024 – volume: 100 start-page: 109 year: 2008 ident: ref_152 article-title: Therapeutic Targeting of Neuropilin-2 on Colorectal Carcinoma Cells Implanted in the Murine Liver publication-title: JNCI J. Natl. Cancer Inst. doi: 10.1093/jnci/djm279 – volume: 5 start-page: 2995 year: 2009 ident: ref_58 article-title: Improving chitosan-mediated gene transfer by the introduction of intracellular buffering moieties into the chitosan backbone publication-title: Acta Biomater. doi: 10.1016/j.actbio.2009.04.021 – volume: 362 start-page: 893 year: 2018 ident: ref_4 article-title: The paradox of mutations and cancer publication-title: Science doi: 10.1126/science.aav5697 – volume: 93 start-page: 389 year: 2003 ident: ref_59 article-title: Efficient gene delivery by urocanic acid-modified chitosan publication-title: J. Control. Release doi: 10.1016/j.jconrel.2003.08.017 – ident: ref_74 doi: 10.3390/molecules25173982 – ident: ref_106 – volume: 35 start-page: 6369 year: 2014 ident: ref_55 article-title: Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes publication-title: Biomaterials doi: 10.1016/j.biomaterials.2014.04.095 – volume: 15 start-page: 16982 year: 2021 ident: ref_122 article-title: Lipid Nanoparticles—From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement publication-title: ACS Nano doi: 10.1021/acsnano.1c04996 – volume: 12 start-page: 280 year: 2001 ident: ref_18 article-title: Effects of Structure of β-Cyclodextrin-Containing Polymers on Gene Delivery publication-title: Bioconjug. Chem. doi: 10.1021/bc0001084 – volume: 315 start-page: 1 year: 2019 ident: ref_137 article-title: Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release publication-title: J. Control. Release doi: 10.1016/j.jconrel.2019.09.018 – volume: 29 start-page: 223 year: 2018 ident: ref_139 article-title: In Vivo Ovarian Cancer Gene Therapy Using CRISPR-Cas9 publication-title: Hum. Gene Ther. doi: 10.1089/hum.2017.209 – ident: ref_50 doi: 10.3390/md17060381 – volume: 9 start-page: 2591 year: 2012 ident: ref_22 article-title: Folate-PEG-Appended Dendrimer Conjugate with α-Cyclodextrin as a Novel Cancer Cell-Selective siRNA Delivery Carrier publication-title: Mol. Pharm. doi: 10.1021/mp300188f – volume: 12 start-page: 2341 year: 2016 ident: ref_42 article-title: Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo publication-title: Nanomed. Nanotechnol. Biol. Med. doi: 10.1016/j.nano.2016.06.014 – volume: 9 start-page: 971 year: 2018 ident: ref_10 article-title: Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers publication-title: Front. Pharmacol. doi: 10.3389/fphar.2018.00971 – volume: 558 start-page: 99 year: 2004 ident: ref_80 article-title: Atomic force microscopy studies of generation 4 poly(amidoamine) (PAMAM) dendrimers on functionalized surfaces publication-title: Surf. Sci. doi: 10.1016/j.susc.2004.03.049 – volume: 8 start-page: 2101 year: 2013 ident: ref_38 article-title: Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S42440 – volume: 104 start-page: 91 year: 2005 ident: ref_127 article-title: Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats publication-title: J. Control. Release doi: 10.1016/j.jconrel.2005.01.008 – volume: 10 start-page: 21446 year: 2020 ident: ref_86 article-title: Lipodendriplexes mediated enhanced gene delivery: A cellular to pre-clinical investigation publication-title: Sci. Rep. doi: 10.1038/s41598-020-78123-6 – volume: 25 start-page: 1476 year: 2017 ident: ref_67 article-title: Polyplex Evolution: Understanding Biology, Optimizing Performance publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2017.01.024 – volume: 566 start-page: 185 year: 2019 ident: ref_140 article-title: Liposome mediated-CYP1A1 gene silencing nanomedicine prepared using lipid film-coated proliposomes as a potential treatment strategy of lung cancer publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2019.04.078 – volume: 2 start-page: 1271 year: 2021 ident: ref_1 article-title: Reflecting on the golden age of cancer research publication-title: Nat. Cancer doi: 10.1038/s43018-021-00313-6 – volume: 164 start-page: 256 year: 2012 ident: ref_79 article-title: Polymeric nucleic acid carriers: Current issues and novel design approaches publication-title: J. Control. Release doi: 10.1016/j.jconrel.2012.06.036 – volume: 121 start-page: 1941 year: 2017 ident: ref_97 article-title: Structural Comparisons of PEI/DNA and PEI/siRNA Complexes Revealed with Molecular Dynamics Simulations publication-title: J. Phys. Chem. B doi: 10.1021/acs.jpcb.6b10775 – ident: ref_7 doi: 10.3390/pharmaceutics12020102 – volume: 84 start-page: 3642 year: 2019 ident: ref_155 article-title: Emulsifier Composition of Solid Lipid Nanoparticles (SLN) Affects Mechanical and Barrier Properties of SLN-Protein Composite Films publication-title: J. Food Sci. doi: 10.1111/1750-3841.14950 – volume: 10 start-page: 1299 year: 2013 ident: ref_46 article-title: Cationic α-Cyclodextrin:Poly(ethylene glycol) Polyrotaxanes for siRNA Delivery publication-title: Mol. Pharm. doi: 10.1021/mp300449t – ident: ref_109 – volume: 45 start-page: fuab035 year: 2021 ident: ref_163 article-title: The Immunopathobiology of SARS-CoV-2 Infection publication-title: FEMS Microbiol. Rev. doi: 10.1093/femsre/fuab035 – volume: 162 start-page: 407 year: 2012 ident: ref_61 article-title: Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles publication-title: J. Control. Release doi: 10.1016/j.jconrel.2012.07.006 – volume: 39 start-page: 268 year: 2014 ident: ref_20 article-title: Dendrimer as nanocarrier for drug delivery publication-title: Prog. Polym. Sci. doi: 10.1016/j.progpolymsci.2013.07.005 – volume: 364 start-page: 127 year: 2008 ident: ref_56 article-title: Methylated N-(4-pyridinylmethyl) chitosan as a novel effective safe gene carrier publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2008.08.003 – volume: 9 start-page: 15825 year: 2019 ident: ref_103 article-title: Therapeutic potential of functionalized siRNA nanoparticles on regression of liver cancer in experimental mice publication-title: Sci. Rep. doi: 10.1038/s41598-019-52142-4 – volume: 35 start-page: 401 year: 2014 ident: ref_24 article-title: Cyclodextrins in non-viral gene delivery publication-title: Biomaterials doi: 10.1016/j.biomaterials.2013.09.061 – volume: 12 start-page: 4916 year: 2006 ident: ref_151 article-title: Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-06-0021 – ident: ref_49 – volume: 37 start-page: 2523 year: 2019 ident: ref_147 article-title: A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2019.37.15_suppl.2523 – volume: 581 start-page: 119269 year: 2020 ident: ref_148 article-title: Axial pharmaceutical properties of liposome in cancer therapy: Recent advances and perspectives publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2020.119269 – volume: 35 start-page: 1725 year: 2014 ident: ref_85 article-title: Optimization of PAMAM-gold nanoparticle conjugation for gene therapy publication-title: Biomaterials doi: 10.1016/j.biomaterials.2013.11.026 – volume: 4 start-page: 130 year: 2012 ident: ref_37 article-title: Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for DNA, shRNA and siRNA publication-title: Pharmaceutics doi: 10.3390/pharmaceutics4010130 – volume: 14 start-page: 1971 year: 2019 ident: ref_138 article-title: Dual pH-sensitive liposomes with low pH-triggered sheddable PEG for enhanced tumor-targeted drug delivery publication-title: Nanomedicine doi: 10.2217/nnm-2018-0510 – ident: ref_17 doi: 10.3390/molecules24142570 – volume: 87 start-page: 108 year: 2015 ident: ref_149 article-title: Preclinical and clinical development of siRNA-based therapeutics publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2015.01.007 – volume: 5 start-page: 8183 year: 2017 ident: ref_27 article-title: Impact of structurally modifying hyaluronic acid on CD44 interaction publication-title: J. Mater. Chem. B doi: 10.1039/C7TB01895A – volume: 57 start-page: 2177 year: 2005 ident: ref_21 article-title: Dendrimers in gene delivery publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2005.09.017 – volume: 546 start-page: 215 year: 2018 ident: ref_83 article-title: Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2018.05.045 – volume: 103 start-page: 18238 year: 2006 ident: ref_3 article-title: Human cancers express a mutator phenotype publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0607057103 – volume: 9 start-page: 297 year: 2019 ident: ref_14 article-title: Gene Therapy Leaves a Vicious Cycle publication-title: Front. Oncol. doi: 10.3389/fonc.2019.00297 – volume: 111 start-page: 358 year: 2021 ident: ref_162 article-title: A Fully Integrated Online Platform For Real Time Monitoring Of Multiple Product Quality Attributes In Biopharmaceutical Processes For Monoclonal Antibody Therapeutics publication-title: J. Pharm. Sci. doi: 10.1016/j.xphs.2021.09.011 – volume: 21 start-page: 1087 year: 2010 ident: ref_60 article-title: Efficient Gene Transfection by Histidine-Modified Chitosan through Enhancement of Endosomal Escape publication-title: Bioconjug. Chem. doi: 10.1021/bc1000609 – volume: 12 start-page: 3453 year: 2021 ident: ref_117 article-title: Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir publication-title: Nat. Commun. doi: 10.1038/s41467-021-23668-x – volume: 19 start-page: 31 year: 2021 ident: ref_132 article-title: Protein liposomes-mediated targeted acetylcholinesterase gene delivery for effective liver cancer therapy publication-title: J. Nanobiotechnol. doi: 10.1186/s12951-021-00777-9 – volume: 34 start-page: 2480 year: 2013 ident: ref_48 article-title: Cellular Internalization and Gene Silencing of siRNA Polyplexes by Cytocleavable Cationic Polyrotaxanes with Tailored Rigid Backbones publication-title: Biomaterials doi: 10.1016/j.biomaterials.2012.12.006 – volume: 7 start-page: 2274 year: 2017 ident: ref_87 article-title: Surface PEGylation of Mesoporous Silica Nanorods (MSNR): Effect on loading, release, and delivery of mitoxantrone in hypoxic cancer cells publication-title: Sci. Rep. doi: 10.1038/s41598-017-02531-4 – volume: 9 start-page: 857 year: 2018 ident: ref_129 article-title: Long circulating liposomes: Challenges and opportunities publication-title: Ther. Deliv. doi: 10.4155/tde-2018-0035 – volume: 14 start-page: 42 year: 2017 ident: ref_33 article-title: Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases Model publication-title: Mol. Pharm. doi: 10.1021/acs.molpharmaceut.6b00646 – volume: 9 start-page: 557 year: 2018 ident: ref_160 article-title: A review on the role of lipid-based nanoparticles in medical diagnosis and imaging publication-title: Ther. Deliv. doi: 10.4155/tde-2018-0020 – volume: 8 start-page: 1455 year: 2011 ident: ref_34 article-title: Cyclodextrin-based siRNA delivery nanocarriers: A state-of-the-art review publication-title: Expert Opin. Drug Deliv. doi: 10.1517/17425247.2011.610790 – volume: 10 start-page: 1654 year: 2003 ident: ref_92 article-title: A comparison of linear and branched polyethylenimine (PEI) with DCChol/DOPE liposomes for gene delivery to epithelial cells in vitro and in vivo publication-title: Gene Ther. doi: 10.1038/sj.gt.3302050 – volume: 116 start-page: 2602 year: 2016 ident: ref_98 article-title: Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release publication-title: Chem. Rev. doi: 10.1021/acs.chemrev.5b00346 – volume: 547 start-page: 222 year: 2017 ident: ref_146 article-title: Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer publication-title: Nature doi: 10.1038/nature23003 – volume: 51 start-page: 2647 year: 2018 ident: ref_2 article-title: Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview publication-title: Cell. Physiol. Biochem. doi: 10.1159/000495956 – volume: 6 start-page: 17890 year: 2021 ident: ref_28 article-title: Water-Soluble Blue Fluorescent Nonconjugated Polymer Dots from Hyaluronic Acid and Hydrophobic Amino Acids publication-title: ACS Omega doi: 10.1021/acsomega.1c01343 – volume: 8 start-page: 16091 year: 2016 ident: ref_62 article-title: Carbohydrate-based amphiphilic nano delivery systems for cancer therapy publication-title: Nanoscale doi: 10.1039/C6NR04489A – volume: 22 start-page: 927 year: 2014 ident: ref_35 article-title: Preparation and evaluation of polyamidoamine dendrimer conjugate with glucuronylglucosyl-β-cyclodextrin (G3) as a novel carrier for siRNA publication-title: J. Drug Target. doi: 10.3109/1061186X.2014.950663 – volume: 21 start-page: 231 year: 2020 ident: ref_133 article-title: Development and In Vitro Evaluation of Long Circulating Liposomes for Targeted Delivery of Gemcitabine and Irinotecan in Pancreatic Ductal Adenocarcinoma publication-title: AAPS PharmSciTech doi: 10.1208/s12249-020-01745-6 – volume: 60 start-page: 410 year: 2007 ident: ref_31 article-title: Click Bioconjugation of a Well-Defined Synthetic Polymer and a Protein Transduction Domain publication-title: Aust. J. Chem. doi: 10.1071/CH07052 – volume: 24 start-page: 398 year: 2013 ident: ref_69 article-title: Modeling the proton sponge hypothesis: Examining proton sponge effectiveness for enhancing intracellular gene delivery through multiscale modeling publication-title: J. Biomater. Sci. Polym. Ed. doi: 10.1080/09205063.2012.690282 – volume: 9 start-page: 325 year: 2009 ident: ref_99 article-title: Current advances in research and clinical applications of PLGA-based nanotechnology publication-title: Expert Rev. Mol. Diagn. doi: 10.1586/erm.09.15 – volume: 5 start-page: 622 year: 2008 ident: ref_159 article-title: Cationic Solid Lipid Nanoparticles Reconstituted from Low Density Lipoprotein Components for Delivery of siRNA publication-title: Mol. Pharm. doi: 10.1021/mp8000233 – volume: 55 start-page: 1397 year: 1995 ident: ref_145 article-title: Characterization of a Messenger RNA Polynucleotide Vaccine Vector publication-title: Cancer Res. – ident: ref_41 doi: 10.3390/molecules24010004 – volume: 315 start-page: 158 year: 2006 ident: ref_52 article-title: A novel chitosan oligosaccharide–stearic acid micelles for gene delivery: Properties and in vitro transfection studies publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2006.02.026 – volume: 14 start-page: 1084 year: 2019 ident: ref_118 article-title: The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs publication-title: Nat. Nanotechnol. doi: 10.1038/s41565-019-0591-y – volume: 122 start-page: 23 year: 2013 ident: ref_16 article-title: Immune responses to AAV vectors: Overcoming barriers to successful gene therapy publication-title: Blood doi: 10.1182/blood-2013-01-306647 – volume: 106 start-page: 782 year: 2006 ident: ref_45 article-title: Cyclodextrin Rotaxanes and Polyrotaxanes publication-title: Chem. Rev. doi: 10.1021/cr970027+ – ident: ref_82 – volume: 1820 start-page: 188 year: 2012 ident: ref_25 article-title: Regulation of iron transport and the role of transferrin publication-title: Biochim. Biophys. Acta-Gen. Subj. doi: 10.1016/j.bbagen.2011.10.013 – volume: 18 start-page: 156 year: 2019 ident: ref_100 article-title: Preparation and Characterization of PLGA Nanoparticles Containing Plasmid DNA Encoding Human IFN-lambda-1/IL-29 publication-title: Iran. J. Pharm. Res. IJPR – volume: 43 start-page: 8264 year: 2010 ident: ref_78 article-title: Complexation of siRNA with Dendrimer: A Molecular Modeling Approach publication-title: Macromolecules doi: 10.1021/ma1012495 – volume: 1029 start-page: 91 year: 1990 ident: ref_134 article-title: Liposomes for the sustained drug release in vivo publication-title: Biochim. Biophys. Acta-Biomembr. doi: 10.1016/0005-2736(90)90440-Y – volume: 8 start-page: 7498 year: 2018 ident: ref_101 article-title: PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer publication-title: Sci. Rep. doi: 10.1038/s41598-018-25930-7 – volume: 49 start-page: 88 year: 2019 ident: ref_95 article-title: Impact of physicochemical properties of DNA/PEI complexes on transient transfection of mammalian cells publication-title: New Biotechnol. doi: 10.1016/j.nbt.2018.09.005 – volume: 115 start-page: 115 year: 2017 ident: ref_8 article-title: Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2017.07.021 – volume: 34 start-page: 721 year: 2009 ident: ref_26 article-title: Advances in Systemic siRNA Delivery publication-title: Drugs Future doi: 10.1358/dof.2009.34.9.1413267 – volume: 530 start-page: 291 year: 2017 ident: ref_84 article-title: In vitro studies of phospholipid-modified PAMAM-siMDR1 complexes for the reversal of multidrug resistance in human breast cancer cells publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2017.06.026 – volume: 10 start-page: 2730 year: 2013 ident: ref_43 article-title: Synergistic Combination of Small Molecule Inhibitor and RNA Interference against Antiapoptotic Bcl-2 Protein in Head and Neck Cancer Cells publication-title: Mol. Pharm. doi: 10.1021/mp4001662 – volume: 65 start-page: 1686 year: 2013 ident: ref_120 article-title: Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2013.09.004 – volume: 14 start-page: 4071 year: 2013 ident: ref_54 article-title: Cell Penetrating Peptide Conjugated Polymeric Micelles as a High Performance Versatile Nonviral Gene Carrier publication-title: Biomacromolecules doi: 10.1021/bm401204n – volume: 13 start-page: 3754 year: 2019 ident: ref_114 article-title: Lipid-Based DNA Therapeutics: Hallmarks of Non-Viral Gene Delivery publication-title: ACS Nano doi: 10.1021/acsnano.8b07858 – volume: 6 start-page: 1078 year: 2021 ident: ref_124 article-title: Lipid nanoparticles for mRNA delivery publication-title: Nat. Rev. Mater. doi: 10.1038/s41578-021-00358-0 – volume: 268 start-page: 235 year: 1990 ident: ref_135 article-title: Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes publication-title: FEBS Lett. doi: 10.1016/0014-5793(90)81016-H – volume: 7 start-page: 2508 year: 2021 ident: ref_141 article-title: Cancer Stem Cell-Targeted Gene Delivery Mediated by Aptamer-Decorated pH-Sensitive Nanoliposomes publication-title: ACS Biomater. Sci. Eng. doi: 10.1021/acsbiomaterials.1c00110 – volume: 35 start-page: 3865 year: 2014 ident: ref_23 article-title: Star-shaped cyclodextrin-poly(l-lysine) derivative co-delivering docetaxel and MMP-9 siRNA plasmid in cancer therapy publication-title: Biomaterials doi: 10.1016/j.biomaterials.2014.01.040 – volume: 47 start-page: 83 year: 2001 ident: ref_51 article-title: Polysaccharide colloidal particles as delivery systems for macromolecules publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/S0169-409X(00)00123-X – volume: 82 start-page: 158 year: 2018 ident: ref_107 article-title: Pharmacokinetics and efficacy of orally administered polymeric chloroquine as macromolecular drug in the treatment of inflammatory bowel disease publication-title: Acta Biomater. doi: 10.1016/j.actbio.2018.10.027 – volume: 50 start-page: 8202 year: 2017 ident: ref_81 article-title: Tuning DNA Condensation with Zwitterionic Polyamidoamine (zPAMAM) Dendrimers publication-title: Macromolecules doi: 10.1021/acs.macromol.7b01470 – volume: 12 start-page: 2294 year: 2021 ident: ref_128 article-title: A Review on Drug Delivery System for Tumor Therapy publication-title: Front. Pharmacol. – volume: 1664 start-page: 70 year: 2004 ident: ref_150 article-title: DOTAP/DOPE and DC-Chol/DOPE lipoplexes for gene delivery: Zeta potential measurements and electron spin resonance spectra publication-title: Biochim. Biophys. Acta-Biomembr. doi: 10.1016/j.bbamem.2004.04.003 – volume: 6 start-page: 3585 year: 2020 ident: ref_29 article-title: Sulfation Modulates the Targeting Properties of Hyaluronic Acid to P-Selectin and CD44 publication-title: ACS Biomater. Sci. Eng. doi: 10.1021/acsbiomaterials.0c00115 – ident: ref_156 doi: 10.5772/54781 – volume: 158 start-page: 63 year: 2012 ident: ref_130 article-title: In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domain publication-title: J. Control. Release doi: 10.1016/j.jconrel.2011.10.013 – volume: 56 start-page: 1161 year: 2004 ident: ref_36 article-title: Folate receptor-targeted immunotherapy of cancer: Mechanism and therapeutic potential publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2004.01.009 – volume: 18 start-page: 565 year: 2015 ident: ref_75 article-title: PAMAM dendrimers as promising nanocarriers for RNAi therapeutics publication-title: Mater. Today doi: 10.1016/j.mattod.2015.06.003 – volume: 13 start-page: 1073 year: 2016 ident: ref_112 article-title: Delivery of miR-200c Mimic with Poly(amido amine) CXCR4 Antagonists for Combined Inhibition of Cholangiocarcinoma Cell Invasiveness publication-title: Mol. Pharm. doi: 10.1021/acs.molpharmaceut.5b00894 – volume: 110 start-page: 2609 year: 2021 ident: ref_13 article-title: Manufacturing Challenges and Rational Formulation Development for AAV Viral Vectors publication-title: J. Pharm. Sci. doi: 10.1016/j.xphs.2021.03.024 – volume: 2 start-page: e121 year: 2013 ident: ref_153 article-title: Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (-) and ER (+) Breast Cancer publication-title: Mol. Ther. Nucleic Acids doi: 10.1038/mtna.2013.45 – volume: 1 start-page: e37 year: 2012 ident: ref_121 article-title: Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA publication-title: Mol. Ther.-Nucleic Acids doi: 10.1038/mtna.2012.28 – volume: 15 start-page: 243 year: 2004 ident: ref_142 article-title: Combination with liposome-entrapped, ends-modified raf antisense oligonucleotide (LErafAON) improves the anti-tumor efficacies of cisplatin, epirubicin, mitoxantrone, docetaxel and gemcitabine publication-title: Anticancer Drugs doi: 10.1097/00001813-200403000-00009 – ident: ref_11 doi: 10.5772/54862 – volume: 19 start-page: 910 year: 2020 ident: ref_116 article-title: A year-long extended release nanoformulated cabotegravir prodrug publication-title: Nat. Mater. doi: 10.1038/s41563-020-0674-z – volume: 2 start-page: 307 year: 2009 ident: ref_104 article-title: Biodegradable Polymers publication-title: Materials doi: 10.3390/ma2020307 |
SSID | ssj0002793479 |
Score | 2.3316662 |
SecondaryResourceType | review_article |
Snippet | The research and development of non-viral gene therapy has been extensive over the past decade and has received a big push thanks to the recent successful... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 6 |
SubjectTerms | Acids Cancer Cancer therapies Gene therapy mRNA Mutation nanoparticles non-viral vectors nucleic acid delivery Nucleic acids polymers Review siRNA Vectors (Biology) |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA7iyYv4xPVFBBEv1bRJ0_a4rooI7mlXvJU8saJdcXcP_ntn0rpsBfHitZmWdDLDfJPMfCHkNLU895kvIpXbPBKK6Qi8yESxVM5mgKG9x-bkh6G8G4v7p_Rp6aovrAlr6IEbxV3GDrmwjRXCItwXWjOueOJSZyXToXs8gTC2lEy9hOO0AlskGy4fDnn9pa6Q9uAZoh3uaMtOGAps_R2I2S2QXIo4txtkvYWKtN9McZOsuHqLbPdrSJPfPukZDcWbYVd8mwyGkzp6rOAr9DHsw08poFF67V6x7uKTTjwdInNxZWjfVJaOQtsVZMlBbIBL_7FDxrc3o8Fd1N6PEBkhxSzygD0KlyLfTuwS8Dxf2JzlSvnMcsul9g5S35x5xhzgQK2sFHHMVZKx1GvB-C5ZrSe12yNUZdwhkXwspREJM4V2hdU-YyZlAjBej1x8q6s0LXk43mHxWkISgfotf-i3R84XL7w3vBm_i16h_hdiSHgdHoAZlK0ZlH-ZQY8cfq9e2XrhtAS5hItm_ieLYfAfPBRRtZvMUSYvWAppZ9IjWWfVOxPqjtTVc2DihuQ1LZjY_48_OCBrCbZWYH1bdkhWZx9zdwSAZ6aPg21_AYxq_3s priority: 102 providerName: Directory of Open Access Journals |
Title | Non-Viral Vectors for Delivery of Nucleic Acid Therapies for Cancer |
URI | https://www.proquest.com/docview/2642344193 https://www.proquest.com/docview/2689052892 https://pubmed.ncbi.nlm.nih.gov/PMC9245904 https://doaj.org/article/1ec080cd44d04264bb03a32e5ed60b71 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2673-6284 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002793479 issn: 2673-6284 databaseCode: DOA dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 2673-6284 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002793479 issn: 2673-6284 databaseCode: ABDBF dateStart: 20210601 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2673-6284 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002793479 issn: 2673-6284 databaseCode: M~E dateStart: 20200101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2673-6284 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002793479 issn: 2673-6284 databaseCode: RPM dateStart: 20200101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2673-6284 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0002793479 issn: 2673-6284 databaseCode: BENPR dateStart: 20120301 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELbK7oULKhREoKyMhBCXUCd24uSA0O62qwqJCKG26i3yk0YqSbvdHvrvmfEmC0GCa-w8NI_MwzPfEPIus7zw0pexKmwRC8V0DFpk4iRXzkrwob3H5uSvVX56Lr5cZpd7pBp6YbCscvgnhh-17QzmyI_AcKccbHfJP9_cxjg1Ck9XhxEaqh-tYD8FiLFHZJriVOUJmS5Oqm_fd1mXFMRRyHKL8cMh3j_SDcIhXIEVxEx3PjJPAcV_5HqOCyf_sESrffKkdyHpfMvzp2TPtc_IwbyF8PnnA31PQ1FnyJYfkGXVtfFFA0-hFyE_f0fBS6XH7hrrMR5o52mFiMaNoXPTWHoW2rEgeg7bligS6-fkfHVytjyN-7kJsRG52MQefJLSZYjDk7gUNNKXtmCFUl5abnmuvYOQuGCeMQf-oVY2F0nCVSpZ5rVg_AWZtF3rXhKqJHcIMJ_kuREpM6V2pdVeMpMx5EVEPg7kqk0PKo6zLa5rCC6QvvVf9I3Ih90NN1s8jX9vXSD9d9sQCDtc6NY_6l6v6sQhVLqxQliMBoXWjCueuszZnGmZRORw4F7da-dd_VuWIvJ2twx6hYclqnXdPe4pSpZBOJpGRI64Pvqg8UrbXAWEbghqs5KJV_9_-WvyOMVmCqxok4dkslnfuzfg4mz0jEzni-PFatbL7yykCn4BUmwAIQ |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKe4ALAgoiUMBIgLiEOrHzOlRou221pe0KoW3VW-onjVSSsrsV2j_Hb2PGmywECW69xo4TjWc8D898Q8ibxPDcZa4IZW7yUEimQpAiHUaptCYDG9o5LE4-GaejU_HpPDlfIz-7WhhMq-zORH9Qm0ZjjHwbFHfMQXcX_OP19xC7RuHtatdCQ7atFcyOhxhrCzuO7OIHuHCzncM92O-3cXywPxmOwrbLQKhFKuahAw1e2ARRayIbA_-6wuQsl9JlhhueKmfBgcyZY8yCNaWkSUUUcRlnLHFKMA7r3iEbYHZwkKqN3f3x5y-rKA8sjaWaS0whzgu2rSqEX7gErYuR9bSnDn3XgJ6p20_U_EPzHTwg91uTlQ6WPPaQrNn6Edkc1OCuf1vQd9Qnkfro_CYZjps6PKtgFXrm7wNmFKxiumevMP9jQRtHx4igXGk60JWhE1_-Bd66nzZEFpw-Jqe3QsEnZL1uavuUUJlxi4D2UZpqETNdKFsY5TKmE4Z7H5APHblK3YKYYy-NqxKcGaRv-Rd9A_J-9cL1Er_j31N3kf6raQi87R80069lK8dlZBGaXRshDHqfQinGJY9tYk3KVBYFZKvbvbI9DWblb94NyOvVMMgxXs7I2jY3OCcvWALubxyQrLfrvR_qj9TVpUcEByc6KZh49v-PvyJ3R5OT4_L4cHz0nNyLsZADs-myLbI-n97YF2BezdXLlocpubhtsfkFX8k5fw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTkK8IGAgygYYCRAvoU7sfD1MqGtXbQyiCW3T3oId26zSloy2E-q_yF_FXZoUggRve40dJzrf-T589zuA16ERiYtd6qnEJJ5UXHsoRYXnR8qaGG1o56g4-XMWHZzKj-fh-Qb8bGthKK2yPRPrg9pUBcXIB6i4A4G6OxUD16RFHI8nH66_e9RBim5a23YaqmmzYHZruLGmyOPILn-gOzffPRzj3r8Jgsn-yejAazoOeIWM5MJzqM1TGxKCjW8D5GWXmoQnSrnYCCMi7Sw6kwl3nFu0rLQykfR9oYKYh05LLnDdO7AZU71oDzb39rPjL-uIDy5NZZsrfCEhUj7QU4JiuEANTFH2qKMa6w4CHbO3m7T5hxacPID7jfnKhit-ewgbtnwEW8MSXferJXvL6oTSOlK_BaOsKr2zKa7Czuq7gTlDC5mN7SXlgixZ5VhGaMrTgg2LqWEndSkYeu71tBGx4-wxnN4KBZ9Ar6xK-xSYioUlcHs_igoZ8CLVNjXaxbwIOfFBH9635MqLBtCc-mpc5ujYEH3zv-jbh3frF65XWB7_nrpH9F9PIxDu-kE1-5Y3Mp37lmDaCyOlIU9Uas2FEoENrYm4jv0-7LS7lzcnwzz_zcd9eLUeRpmmixpV2uqG5iQpD9EVDvoQd3a980PdkXJ6UaODo0Mdplw--__HX8JdFJ_802F2tA33AqrpoMS6eAd6i9mNfY6W1kK_aFiYwdfblppf6F49uQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Non-Viral+Vectors+for+Delivery+of+Nucleic+Acid+Therapies+for+Cancer&rft.jtitle=Biotech+%28Basel%29&rft.au=Kanvinde%2C+Shrey&rft.au=Kulkarni%2C+Tanmay&rft.au=Deodhar%2C+Suyash&rft.au=Bhattacharya%2C+Deep&rft.date=2022-03-07&rft.pub=MDPI+AG&rft.eissn=2673-6284&rft.volume=11&rft.issue=1&rft.spage=6&rft_id=info:doi/10.3390%2Fbiotech11010006&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2673-6284&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2673-6284&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2673-6284&client=summon |